Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
MBX Biosciences, Inc. (MBX) had Pre-Tax Income of $-19.41M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-19.41M |
|
-- |
|
-- |
|
$21.80M |
|
$-21.80M |
|
$2.39M |
|
|
Pre-Tax Income |
$-19.41M |
$-19.41M |
|
$-19.41M |
|
$-19.41M |
|
$-19.41M |
|
$-19.41M |
|
$-21.80M |
|
$-21.74M |
|
33.45M |
|
33.45M |
|
$-0.58 |
|
$-0.58 |
|
| Balance Sheet Financials | |
$229.19M |
|
$1.73M |
|
$2.33M |
|
$231.52M |
|
$11.76M |
|
-- |
|
$0.53M |
|
$12.28M |
|
$219.24M |
|
$219.24M |
|
$219.24M |
|
33.59M |
|
| Cash Flow Statement Financials | |
$-40.11M |
|
$29.21M |
|
$1.33M |
|
$49.35M |
|
$39.78M |
|
$-9.57M |
|
$3.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-40.85M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.85% |
|
-8.85% |
|
-8.38% |
|
-8.85% |
|
$6.53 |
|
$-1.22 |
|
$-1.20 |
|